NEW YORK (GenomeWeb) – Abbott Laboratories attempted to terminate its pending merger with Alere, Alere said late on Thursday. 

The firm has twice delayed filing its 2015 earnings report, leading Abbott to inform Alere that "it has serious concerns about, among other things, the accuracy of various representations, warranties and covenants made by Alere in the parties' merger agreement," Alere said. Abbott even offered to pay Alere a termination fee of $30 million to $50 million to pay for Alere's transaction expenses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.